CONNECTA Therapeutics announces new investment to advance clinical development of Fragile X Syndrome… EP News Bureau Sep 15, 2026 CONNECTA Therapeutics, a clinical-stage biotech company pioneering first-in-class neuroplasticity modulators to address unmet…
